UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Cognitive function and fatigue after diagnosis of colorectal cancer

Annals of oncology, 2014-12, Vol.25 (12), p.2404-2412

2014

Volltextzugriff (PDF)

P021 A pragmatic randomised, multicentre trial evaluating the dose timing (morning vs evening) of endocrine therapy for early breast cancer (REaCT-CHRONO Study)

Breast (Edinburgh), 2023-04, Vol.68, p.S24-S25

2023

Volltextzugriff (PDF)

P1.15-10 Chronic Obstructive Pulmonary Disease Patients Receiving Immunotherapy for Lung Cancer: A Population-Based Study in Canada

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S124

2022

Volltextzugriff (PDF)

C-statistic: A brief explanation of its construction, interpretation and limitations

European journal of cancer (1990), 2018-02, Vol.90, p.130-132

2018

Volltextzugriff (PDF)

Impact of the Number of Prior Lines of Therapy and Prior Perioperative Chemotherapy in Patients Receiving Salvage Therapy for Advanced Urothelial Carcinoma: Implications for Trial Design

Clinical genitourinary cancer, 2015-02, Vol.13 (1), p.71-79

2015

Volltextzugriff (PDF)

Social determinants of health in uterine cancer patients in Ontario: Association with disease presentation and outcomes

Gynecologic oncology, 2020-10, Vol.159, p.66-66

2020

Volltextzugriff (PDF)

Predictors of Minimally Invasive Surgery for Uterine and Cervix Cancer from 2000 – 2017 in Ontario, Canada

Gynecologic oncology, 2020-10, Vol.159, p.273-274

2020

Volltextzugriff (PDF)

Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy

BMC cancer, 2024-08, Vol.24 (1), p.1-7, Article 984

2024

Volltextzugriff (PDF)

Prognostic ability of early tumor shrinkage on overall survival (OS) in metastatic renal cell carcinoma (mRCC) – a validation study

Annals of oncology, 2016-10, Vol.27, p.vi283-vi283

2016

Volltextzugriff (PDF)

Prognostic ability of HR-QoL parameters in metastatic renal cell carcinoma (mRCC)

Annals of oncology, 2016-10, Vol.27, p.vi285-vi285

2016

Volltextzugriff (PDF)

Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials

Annals of oncology, 2013-12, Vol.24 (12), p.2972-2977

2013

Volltextzugriff (PDF)

Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study

Annals of oncology, 2016-09, Vol.27 (9), p.1761-1767

2016

Volltextzugriff (PDF)

Factors Influencing the Use of Single vs Multiple Fractions of Palliative Radiotherapy for Bone Metastases: A 5-Year Review

Clinical oncology (Royal College of Radiologists (Great Britain)), 2005-09, Vol.17 (6), p.430-434

2005

Volltextzugriff (PDF)

Cardiac Morbidity Following Chemoradiation in Stage III Non-small Cell Lung Cancer Patients: A Population-Based Cohort Study

Clinical oncology (Royal College of Radiologists (Great Britain)), 2023-02, Vol.35 (2), p.e182-e188

2023

Volltextzugriff (PDF)

Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy

Annals of oncology, 2014-05, Vol.25 (5), p.992-998

2014

Volltextzugriff (PDF)

A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer

Annals of oncology, 2020-07, Vol.31 (7), p.951-957

2020

Volltextzugriff (PDF)

Concurrent Pemetrexed/Cisplatin/Radiation for Unresectable Stage IIIA/B Non-Small Cell Lung Cancer: A Phase I/II Study

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S490-S490

2007

Volltextzugriff (PDF)

Everolimus, when combined with exemestane, adds toxicity with minimal benefit for women with breast cancer

Annals of oncology, 2014-10, Vol.25 (10), p.2096-2096

2014

Volltextzugriff (PDF)

Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa

Annals of oncology, 2008-10, Vol.19 (10), p.1749-1753

2008

Volltextzugriff (PDF)

Efficacy and safety of gemcitabine plus either taxane or carboplatin in the first-line setting of metastatic urothelial carcinoma: a systematic review and meta-analysis

Clinical genitourinary cancer, 2017-02, Vol.15 (1), p.23-30.e2

2017

Volltextzugriff (PDF)

Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus

European journal of cancer (1990), 2006-08, Vol.42 (12), p.1875-1880

2006

Volltextzugriff (PDF)

Dovitinib in advanced adenoid cystic carcinoma of the salivary glands: Ontario Clinical Oncology Group DOVE trial

Annals of oncology, 2016-10, Vol.27, p.vi335-vi335

2016

Volltextzugriff (PDF)

Influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trials

Annals of oncology, 2010-01, Vol.21 (1), p.19-26

2010

Volltextzugriff (PDF)

Phase II multicenter open‐label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies

International journal of gynecological cancer, 2005-09, Vol.15 (5), p.799-806

2005

Volltextzugriff (PDF)

Outcomes of patients with metastatic urothelial carcinoma (mUC) with exclusive bone metastases: Focus on a special patient population

Annals of oncology, 2017-09, Vol.28, p.v308-v309

2017

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(53)

Sprache

Englisch
(53)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Oncology
(26)
Humans
(24)
Female
(16)
Aged
(13)
Middle Aged
(13)
Biological And Medical Sciences
(12)
Male
(12)
Medical Sciences
(11)
Pharmacology. Drug Treatments
(10)
Adult
(9)
Antineoplastic Agents
(9)
Treatment Outcome
(8)
Tumors
(7)
Hematology, Oncology And Palliative Medicine
(6)
Survival Analysis
(6)
Chemotherapy
(5)
Urology
(5)
Aged, 80 And Over
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cognitive function and fatigue after diagnosis of colorectal cancer

P021 A pragmatic randomised, multicentre trial evaluating the dose timing (morning vs evening) of endocrine therapy for early breast cancer (REaCT-CHRONO Study)

P1.15-10 Chronic Obstructive Pulmonary Disease Patients Receiving Immunotherapy for Lung Cancer: A Population-Based Study in Canada

C-statistic: A brief explanation of its construction, interpretation and limitations

Impact of the Number of Prior Lines of Therapy and Prior Perioperative Chemotherapy in Patients Receiving Salvage Therapy for Advanced Urothelial Carcinoma: Implications for Trial Design

Social determinants of health in uterine cancer patients in Ontario: Association with disease presentation and outcomes

Predictors of Minimally Invasive Surgery for Uterine and Cervix Cancer from 2000 – 2017 in Ontario, Canada

Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy

Prognostic ability of early tumor shrinkage on overall survival (OS) in metastatic renal cell carcinoma (mRCC) – a validation study

Prognostic ability of HR-QoL parameters in metastatic renal cell carcinoma (mRCC)

Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials

Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study

Factors Influencing the Use of Single vs Multiple Fractions of Palliative Radiotherapy for Bone Metastases: A 5-Year Review

Cardiac Morbidity Following Chemoradiation in Stage III Non-small Cell Lung Cancer Patients: A Population-Based Cohort Study

Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy

A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer

Concurrent Pemetrexed/Cisplatin/Radiation for Unresectable Stage IIIA/B Non-Small Cell Lung Cancer: A Phase I/II Study

Everolimus, when combined with exemestane, adds toxicity with minimal benefit for women with breast cancer

Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa

Efficacy and safety of gemcitabine plus either taxane or carboplatin in the first-line setting of metastatic urothelial carcinoma: a systematic review and meta-analysis

Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus

Dovitinib in advanced adenoid cystic carcinoma of the salivary glands: Ontario Clinical Oncology Group DOVE trial

Influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trials

Phase II multicenter open‐label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies

Outcomes of patients with metastatic urothelial carcinoma (mUC) with exclusive bone metastases: Focus on a special patient population

Suchergebnisse filtern